Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Techniques & Tools

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2025 / Articles / Apr / Coming Soon: the Power List
Manufacture Advanced Medicine Small Molecules Small Molecules

Coming Soon: the Power List

The 2025 Power List will be available soon!

By Rob Coker 04/11/2025 2 min read

Share

Look out for the 2025 Power List on April 28!

Whether you’re a bench scientist, a biotech founder, or someone passionate about the future of healthcare, the 2025 Power List offers plenty of reasons to be inspired. While you wait for the 2025 list, why not remind yourself of 2024’s big hitters.

From the minds behind life-saving medicines to the innovators driving new manufacturing and AI solutions, the Power List has become an annual tradition at The Medicine Maker over the last decade, highlighting the researchers, entrepreneurs, and industry stakeholders pushing inspiring progress in drug development and manufacturing. The 2025 edition will shine a spotlight on 30 influential figures whose work is shaping the future of human health.

This year’s honorees include cell and gene therapy pioneers, sustainability advocates, biologics experts, and small molecules trailblazers. Some are well known around the world; others work behind the scenes – but all are united by a commitment to innovation and impact.

The Power List doesn’t rank individuals or quantify success. Instead, it offers a curated celebration of the diverse expertise and creative thinking that power the pharmaceutical world. Each honoree will be profiled in their own words, giving readers a glimpse into what drives them – and how they see the future of their fields.

The Power List is a reminder of the human talent and tenacity at the heart of every breakthrough. It reinforces the importance of collaboration, as many of those featured credit cross-disciplinary partnerships for their biggest achievements.

Why not check out current content from our previous Power Listers, including:

  • Audrey Greenberg
  • Claudia Zylberberg
  • Carl June
  • Sheila Mikhail
  • Hanns-Christian Mahler

If you enjoy our content, consider signing up for our newsletters to receive regular news and updates straight to your inbox

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Rob Coker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

More Articles by Rob Coker

False

Advertisement

Recommended

False

Related Content

 The Synergy of Science and Business
The Synergy of Science and Business

November 7, 2024

Developing science is good; developing successful commercialization strategies is great.

Don’t Forget CDx Developers
Advanced Medicine
Don’t Forget CDx Developers

November 7, 2014

0 min read

Many drug developers are going ‘full steam ahead’ with personalized medicine strategies. They would be wise to consider a more equitable business model for an essential partner in the process: the developer of the companion diagnostic.

The Next Decade of Cell and Gene Therapies
Advanced Medicine Bioprocessing - Upstream & Downstream Trends & Forecasts Digital Technologies
The Next Decade of Cell and Gene Therapies

May 7, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Peter Marks Resigns from FDA
Standards & Regulation Profession Vaccines Advanced Medicine
Peter Marks Resigns from FDA

April 1, 2025

3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.